Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
9
×
national blog main
9
×
biotech
boston blog main
clinical trials
fda
national top stories
san francisco blog main
national
new york blog main
new york top stories
san francisco top stories
sanofi
startups
amgen
cancer
indiana blog main
indiana top stories
new york
san diego blog main
seattle blog main
seattle top stories
tech
vc
abbvie
akili interactive labs
akouos
alex azar
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew berens
anirvan ghosh
artificial intelligence
astrazeneca
avapritinib
biogen
blood draw
blood tests
What
announced
9
×
drug
medicine
medicines
ceo
plans
week
approval
based
blood
blueprint
cancer
fda
lowering
aces
acquisitions
administration
alex
approved
area
backs
bay
bets
big
bio
biopharma
biopsy
bodily
buildout
captures
chasing
cheaper
cholesterol
class
click
close
collaboration
collabs
collecting
company
Language
unset
Current search:
" national blog main "
×
announced
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Magnolia Medical Captures $20M to Reduce Blood Culture Contamination
@xconomy.com
5 years ago
Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum